Published on 25 Mar 2024 on Investing.com
AXS-12 shows promise in narcolepsy treatment, trial finds By Investing.com
Axsome Therapeutics, Inc. (NASDAQ: NASDAQ:AXSM), a biopharmaceutical company, announced today...
NASDAQ.AXSM price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free